Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15637 | Fluzoparib | 3 | Recruiting | 1 |
| DB14765 | Rivoceranib | 3 | Recruiting | 1 |